NCT07217171
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07217171
Title A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EvolveImmune United, Inc
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
USC/Norris Comprehensive Cancer Center RECRUITING Los Angeles California 90033 United States Details
The Winship Cancer Institute Emory University RECRUITING Atlanta Georgia 30322 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
SCRI RECRUITING Nashville Tennessee 37203 United States Details
Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field